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ABSTRACT The initial concentration of monomeric amyloidogenic proteins is a crucial factor in the in vitro formation of
amyloid ﬁbrils. We use quantitative atomic force microscopy to study the effect of the initial concentration of human a-synuclein
on the mean length of mature a-synuclein ﬁbrils, which are associated with Parkinson’s disease. We determine that the critical
initial concentration, below which low-molecular-weight species dominate and above which ﬁbrils are the dominant species, lies
at;15 mM, in good agreement with earlier measurements using biochemical methods. In the concentration regime where ﬁbrils
dominate, we ﬁnd that their mean length increases with initial concentration. These results correspond well to the qualitative
predictions of a recent statistical-mechanical model of amyloid ﬁbril formation. In addition, good quantitative agreement of the
statistical-mechanical model with the measured mean ﬁbril length as a function of initial protein concentration, as well as with
the ﬁbril length distributions for several protein concentrations, is found for reasonable values of the relevant model parameters.
The comparison between theory and experiment yields, for the ﬁrst time to our knowledge, an estimate of the magnitude of the
free energies associated with the intermolecular interactions that govern a-synuclein ﬁbril formation.
INTRODUCTION
The aggregation of proteins into amyloid or amyloid-like
ﬁbrils is a process of crucial importance in many neurological
disorders (1–3). In the case of Parkinson’s disease (PD), the
hallmark pathological features are Lewy bodies: intracellular
neuronal inclusions consisting mainly of misfolded and
aggregated a-synuclein (4,5). Nanoscale knowledge of the
morphology of the protein aggregates in these inclusions may
help increase understanding of the etiology of the disease.
Earlier biophysical research has shown that aggregates of
various amyloidogenic proteins typically take the form of
thread-like ﬁbrils. These ﬁbrils may assemble hierarchically,
that is, by protoﬁlaments winding together (6), but also by
lateral association without formation of a helical structure
(7,8). Similar ﬁbrillar structures have been observed in vitro
formed by various disease-related and nondisease-related
proteins, such as a-synuclein (6,8–10), glucagon (11,12),
insulin (6,7), amyloid-b (Ab) peptide 1–40 (13), prion pro-
tein (14), and others.
The morphology of the resulting aggregates depends on
such diverse factors as solution conditions (15), the shape of
any preformed aggregates which may serve as nuclei (7), and
mutations in the amino acid sequence of the protein (10).
Based on these observations, structural models describing the
assembly of amyloid ﬁbrils have been proposed. The domi-
nant structural model for a-synuclein ﬁbrillization (6) pro-
poses that two protoﬁlaments (linear chains of b-sheet-folded
monomers) wind together to form an intermediate ﬁbril, and
two of these intermediate ﬁbrils in turn wind together to form
a so-called ‘‘mature ﬁbril’’. Note that various authors use
different terminologies to describe the various species during
the aggregation process. We follow the deﬁnitions of Kodali
and Wetzel (13).
The aggregation of proteins into amyloid ﬁbrils is con-
sidered to be a nucleation-polymerization process (16). As
such, the initial concentration of a-synuclein is expected to
have a profound effect on the ﬁbril length. The concentration
of a-synuclein present in neural cells is a factor relevant to
the etiology of PD, since triplication of the a-synuclein gene
(and subsequent overexpression of the protein) is associ-
ated with familial PD (17). Another clue to the signiﬁcance
of a-synuclein concentration for the etiology of the disease
is that in pathological conditions, a-synuclein aggregates
are also found in glial cells, where in vitro overexpression of
a-synuclein leads to cell death (18). Apart from overexpression,
the ‘‘effective concentration’’ of a-synuclein can also change
from its normal value (which we estimate to be 70–140 mM
in healthy neural cells, see the Materials and Methods sec-
tion) due to reduced degradation or unspeciﬁc molecular
crowding. These effects have been found to signiﬁcantly
reduce the aggregation lag time in in vitro experiments
(19,20).
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To capture the essential factors that allow many different
proteins to form similar ﬁbrils, a general statistical-mechan-
ical model of amyloid ﬁbril formation was recently outlined
(21). This model couples a theory describing self-assembly
and conformational transition to a description of the associ-
ation of linear chains. The model focuses on the formation of
linear, unbranched amyloid ﬁbrils commonly observed in
studies of protein aggregation and does not address amor-
phous aggregation. The model predicts the effect of pro-
tein concentration on the properties of a dilute solution of
ﬁbrillogenic protein molecules, given the free energies
associated with various intermolecular interactions (Fig. 1).
For reasonable values of these free-energy parameters, the
model predicts that there exists a critical concentration below
which most protein molecules are present as free monomers.
It also predicts ﬁbril formation above this concentration, with
the ﬁbril length increasing with protein concentration. The
existence of a critical concentration is consistent with
the notion of amyloid ﬁbril formation being a nucleation-
polymerization process (1,16).
In this investigation, we test the predictions of the statis-
tical-mechanical model introduced in van Gestel and de
Leeuw (21), both qualitatively and quantitatively, using
atomic forcemicroscopy (AFM) to imagematurea-synuclein
ﬁbrils formed in vitro at various initial protein concentrations.
Our experimental results demonstrate that a-synuclein ﬁbril
formation is well described by the model. We determine the
critical concentration for a-synuclein ﬁbrillization to be 15
mM. From the measured dependence of the average ﬁbril
length on the protein concentration, we extract values for the
free energies of interactions in the ﬁbrils: the free energy of
interaction between adjacent b-folded monomers is found to
lie between 16.2 and 15.4 kJ/mol, and the lateral inter-
action between protoﬁlaments in the ﬁbril has a bond energy
between 11.0 and 7.4 kJ/mol.
MATERIALS AND METHODS
Expression, puriﬁcation, and aggregation of
recombinant human a-synuclein
Wild-type a-synuclein (140 aa,M¼ 14,460 Da) was expressed and puriﬁed
as described before (10).
Protein solutions taken from stock at 80C were defrosted and centri-
fuged for 1 h at 21,000 3 g to remove any preformed aggregates or con-
taminating particles. Native gradient polyacrylamide gel electrophoresis
conﬁrmed the presence of only monomeric a-synuclein. The initial protein
concentration was determined by measuring the absorbance at 275 nmwith a
NanoDrop ND-1000 absorption spectrophotometer (NanoDrop Technolo-
gies, Wilmington, DE) and using an extinction coefﬁcient e(275 nm)¼ 5600
M1cm1 (1400 M1cm1 per tyrosine residue). Monomeric a-synuclein
was diluted to the desired initial protein concentrations in the 5–250 mM
range in a buffer containing 10 mM HEPES and 50 mM NaCl at pH 7.4. We
estimate the concentration uncertainty to be 6% for all initial concentrations
based on analysis of absorption measurements and pipetting accuracy.
Aggregation was performed in a temperature-controlled shaking incu-
bator (ThermoMixer, Eppendorf, Hamburg, Germany) at 37C while shak-
ing at 500 rpm. This shaking frequency speeds up the aggregation process to
a manageable timescale but is considered ‘‘gentle’’. Any shear-force-in-
duced ﬁbril breakage would occur to the same extent for all concentration
conditions in this experiment since incubation conditions were equal. The
aggregation of amyloidogenic proteins is not an artifact of agitation: ag-
gregation occurs in undisturbed solutions, only much slower (22). Each vial
contained 400 ml of protein solution, and all aggregations were performed in
duplicate. Before samples were taken out of the aggregation vessels, they
were rotated at an angle and aspirated to maximize homogeneity of the
sample without disrupting any aggregates.
Samples were taken for detailed AFM analysis after 20–28 days, when the
aggregation reactions had reached their ﬁnal equilibrium state as veriﬁed
from ﬁbril morphology measurements. The presence of monomeric protein
in equilibrium with ﬁbrils was conﬁrmed not only by measuring the 275 nm
absorbance of the supernatant after pelleting the ﬁbrils by centrifugation but
also from native gradient polyacrylamide gel electrophoresis.
Acquisition of AFM images
We deposited 4ml aliquots of aggregated protein solutions on freshly cleaved
mica and incubated them for 2min in a humid environment to avoid drying of
the droplet and salt crystal formation. The samples were then gently rinsed
with 200 ml of MilliQ water (resistivity. 18MVcm1; Millipore, Bedford,
MA) and blown dry with a gentle ﬂow of N2(g). Aggregates of all sizes were
found to adhere equally well to freshly cleaved mica without further surface
modiﬁcation (see, for example, Hoyer et al. (9)).
AFM images were acquired on a custom-built standalone AFM instru-
ment (23) and on a Multimode AFMwith a Nanoscope IV controller (Veeco,
Santa Barbara, CA) in tappingmode under ambient conditions. The drying of
protein aggregate samples for imaging in air inﬂuences their morphology
(especially height and periodicity) but does not affect the observed ﬁbril
length. We used Veeco Probes MSCT-AU tip F (Si3N4), nominal tip radius
10 nm, spring constant k ¼ 0.5 N/m; and MikroMasch (Tallinn, Estonia)
NSC36/Cr-Au tip B (Si), nominal tip radius , 10 nm, spring constant k ¼
1.75 N/m. Tapping amplitude was between 50 and 100 nm, depending on tip-
sample adhesion assessed on a measurement-by-measurement basis. For the
aggregates formed by 5 and 10mMa-synuclein solutions, images were taken
FIGURE 1 (A) Schematic and simpliﬁed representation of relevant spe-
cies in a-synuclein ﬁbrillization. Intrinsically disordered monomers (left)
misfold and aggregate to form protoﬁlaments (middle). Mature ﬁbrils (right)
can consist of up to four laterally interacting protoﬁlaments. In this cartoon,
molecules represented by disks possess the b-strand conformation that
characterizes amyloid ﬁbrils, whereas those represented by blobs do not. In
this work we assume that the ﬁbril ends can be in either a b- or a non-b-
conformation. The experimentally observed helical twist in the mature ﬁbril
is not represented in this model. All processes are assumed to be reversible;
(B) all interactions between protein molecules in the ﬁbril have a free energy
associated with them. P is the free energy for the interaction between
b-folded monomers due to cross-b-sheet formation; E is the free energy for
the interaction between a b-folded molecule and a molecule that is in a non-
b-conformation, which is taken to be equal to the free energy between two
non-b monomers; R is the free energy penalty for a transition between a
region along the ﬁbril axis in which the molecules have a b-conformation
and one in which they are in a non-b-state; F is the lateral interaction free
energy. For a full description of the statistical-mechanical model, see van
Gestel and de Leeuw (21).
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at a pixel resolution of 4 nm/pixel (image size 4 mm) for the 20–30 mM
aggregates at 20 nm/pixel (image size 20 mm) and for the 50–250 mM
aggregates at 40 nm/pixel (image size 20 mm).
Measurement of ﬁbril length distributions
Raw AFM height images were processed using Scanning Probe Image
Processor (ImageMetrology, Hørsholm, Denmark) to remove sample tilt and
scanner bow. Sample tilt was removed using manual tilt correction while
monitoring x and y cross sections until both cross sections were horizontal.
Then, any scanner bow artifacts were corrected using a second or third order
average proﬁle ﬁt. To minimize distortion of apparent morphology of the
objects in the image, the ﬁt was calculated excluding these objects by setting
limits on the z color scale. Finally, any line-to-line scanner jumps were
corrected by a zeroth order linewise ﬁt.
Lengths of individual ﬁbrils were measured using segmented line proﬁles
in ImageJ (24). To minimize observer bias, all ﬁbrils that ﬁt the following
criteria were included in the analysis:
1. The ﬁbril lies completely within the image.
2. The ﬁbril can be unambiguously distinguished from any overlapping
ﬁbrils.
3. The ﬁbril appears in the image as larger than four pixels.
We estimate the accuracy of the individual ﬁbril length measurements to
be 40 nm (20 and 30 mM concentrations) and 80 nm (50–250 mM concen-
trations), mainly limited by tip-sample convolution and pixel resolution. The
analysis procedure is demonstrated in Fig. 2.
The aggregates formed by initial concentrations of 5 and 10 mM were
amorphous with reported sizes on the order of 20 nm, which corresponds to
the ‘‘tip-sample-convolution resolution’’. The size of these aggregates was
characterized by their height instead of their length.
Modeling a-synuclein ﬁbril length as a function
of initial concentration
We have adapted a recently outlined statistical-mechanical model of protein
aggregation in dilute solution (21) to the speciﬁc case of a-synuclein ﬁ-
brillization. The model assumes that only two conformational states of the
protein molecules are sufﬁciently populated to have an effect on the aggre-
gation behavior: either proteins can be in a b-strand conformation or they can
be in a less ordered conformation. The model then describes the properties of
mature ﬁbrils in an equilibrium situation. One key prediction is the distri-
bution of the lengths of mature ﬁbrils as a function of initial concentration.
The statistical-mechanical model does not attempt to model the early stages
of aggregation. It would in principle be possible to extend the model to in-
clude parameters that represent monomer conformation. However, for every
conformation taken into account, we need an extra free energy parameter.
A model with an inﬁnite number of adjustable parameters may be com-
plete but will not be very informative. It will also be next to impossible to
independently determine the appropriate values for these parameters from
experimental data. It would also in principle be possible to include an acti-
vation step into the model. However, the concentration of ‘‘activated’’
monomers (that are in a conformation capable of adding to a ﬁbril) will be
extremely small since they would be incorporated into the ﬁbrils immedi-
ately. The equilibrium model then simpliﬁes to one without the activation
step. The kinetics of the process would be inﬂuenced signiﬁcantly by an
activation step, but since our interest lies in the morphology of the resulting
species, that does not pose a problem. Any conformational changes in the
monomers will likely involve such small free energy changes that it would
not signiﬁcantly inﬂuence the predictions of our model if we took them into
account.
The model accounts for three species that participate in the aggregation
process: monomers, protoﬁlaments, and ﬁbrils (Fig. 1). Monomers are de-
ﬁned as single protein molecules that possess a non-b-conformation. Proto-
ﬁlaments are linear chains of interacting monomers, each of which can be
in a non-b-state or in a b-strand state. Mature ﬁbrils are deﬁned as rod-like
aggregates, which in the case of a-synuclein contain up to four protoﬁla-
ments.
Because proteins that possess different conformations interact differently,
we introduce two free-energy parameters: one that accounts for the interac-
tion between two proteins that are both in a b-strand conformation (labeled P
in Fig. 1) and one for the interaction of two proteins that are not both in this
conformation (E). Furthermore, we introduce an interaction free energy for
lateral protein-protein contacts (F) and a free-energy penalty that is applied
whenever an ordered region and a disordered one meet (R). (Note that the
symbols for some of the free energies are different than those in van Gestel
and de Leeuw (21). E replaces M, to avoid confusion with the molar mass,
and P replaces P*, because in the current context it is not necessary to dis-
tinguish between the b-bond free energy and the excess b-bond free energy.)
According to the current structural model of a-synuclein ﬁbrillization, ma-
ture a-synuclein ﬁbrils consist of two intertwined intermediate ﬁbrils, which
in turn consist of two intertwined protoﬁlaments (6). This is reﬂected in the
theory by taking into account only ﬁbrils that consist of four or fewer proto-
ﬁlaments. Each ﬁbril contains (p  1) 3 m lateral protein-protein contacts,
with p the number of protoﬁlaments making up the ﬁbril and m the length of
each protoﬁlament expressed in the number of proteinmolecules. Combining
the model with self-assembly theory allows us to obtain values for the mean
aggregate size, the distribution of ﬁbril lengths, and the mean ﬁbril length.
The temperature at which aggregation is performed (or modeled) affects
the kinetics of amyloidogenesis, but not so much the ﬁbril morphology or the
equilibrium concentrations. In the model, as in the experiment, temperature
was kept constant at the physiologically relevant value of 37C.
Although a full description of the model has been given in van Gestel and
de Leeuw (21), it is appropriate to summarize the theory and present the key
equations here. To describe a polydisperse system of dissolved protein ag-
gregates, two characteristics are of vital importance. The ﬁrst is the number
density r, which gives the total number of particles (aggregates and mono-
mers) that are present in solution, and the second is the volume fraction f of
protein molecules, which in effect counts the total number of protein mol-
ecules present. In van Gestel and de Leeuw (21), these parameters were
determined to equal
r ¼ z1 z2k1 xz
3
k
2
l1
1 zkl11
yz
3
k
2
l2
1 zkl21 +
4
p¼2
rfibrilsðpÞ (1)
and
u ¼ z1 2z2k1 xz
3
k
2
l1ð3 2zkl1Þ
ð1 zkl1Þ2
1
yz
3
k
2
l2ð3 2zkl2Þ
ð1 zkl2Þ2
1 +
4
p¼2
ufibrilsðpÞ; (2)
FIGURE 2 AFM image illustrating the length measurement procedure.
Using the plane-corrected height images (A), lengths were measured
manually for all ﬁbrils that could be resolved individually, did not fall off
the edge of the image, and were larger than four pixels (B). Scale bar 2 mm.
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respectively. In the above equations, x, y, l1, and l2 are prefactors depending
on the description of the protoﬁlament ends (21). These prefactors depend
only on Boltzmann factors s and s (deﬁned below). The equations thus
contain ﬁve variables: the fugacity z ¼ em; with m the chemical potential of
protein molecules given in units of the thermal energy (kBTwith kB Boltzmann’s
constant and T the absolute temperature), and the Boltzmann factors f ¼ eF;
k ¼ eE; s ¼ eP1E; and s ¼ e2R. F, E, P, and R are the free energies
introduced above (Fig. 1) and are also given in terms of the thermal energy.
In Eqs. 1 and 2 the number density and volume fraction have each been
split into ﬁve terms that can be used separately if required. The ﬁrst term in
each equation gives the number density or volume fraction of monomers, the
second term that of dimers, the (combined) third and fourth terms of proto-
ﬁlaments of all lengths, and the ﬁnal term for ﬁbrils of all lengths, containing
p protoﬁlaments. These latter terms equal
rfibrilsðpÞ ¼ f 2ðf 2z2ksÞp 1
ðksfzÞp
f
 1
ð11s1=2kzÞ2p (3)
and
ufibrilsðpÞ ¼
pðksf 2z2Þp
f
2  f ðksfzÞpð11s
1=2
kzÞ2p
3
2 ðksfzÞp=f
1 ðksfzÞp=f 1
2s
1=2
kz
ð11s1=2kzÞ
" #
: (4)
If f and r are known, the mean number of protein molecules per particle
can be calculated as
ÆNæ ¼ u
r
: (5)
By taking the last term from Eqs. 1 and 2, we can calculate the mean
aggregation number for ﬁbrils only in a similar way:
ÆNæfibrils ¼
ufibrils
rfibrils
; (6)
or alternatively, for all ﬁbrils containing p ¼ 4 protoﬁlaments,
ÆNæfibrils;p¼4 ¼ 4
2 ðksfzÞ4=f
1 ðksfzÞ4=f 1
2s
1=2
kz
ð11s1=2kzÞ
" #
: (7)
To calculate the mean length (expressed in number of monomers) of such
ﬁbrils, one then needs only to divide the mean aggregation number by the
number of protoﬁlaments, p:
ÆLæfibrils;p¼4 ¼
ÆNæfibrils;p¼4
4
: (8)
To compare theory and experiment, we need to convert experimental units
to those reﬂected in the theoretical model. The volume fraction of (initially
monomeric) protein u is calculated as u[Vprotein=Vsolution ¼ M3 c=rprotein;
since Vprotein ¼ mprotein=rprotein ¼ c3M3Vsolution=rprotein; where Vprotein is
the volume occupied by the protein molecules, Vsolution is the total volume,
mprotein is the mass of the dissolved protein, c is the protein molar concen-
tration, M is the protein molar mass, and rprotein is the protein mass density.
The mass density of a-synuclein was estimated according to Fischer ((25),
Eq. 2), insertingM¼ 14,460 kDa for the molar mass, giving r ¼ 1.463 103
mg/ml. The mass density is assumed to be constant upon folding and ag-
gregation of the protein. We realize that this assumption may be an over-
simpliﬁcation. However, to our knowledge there are currently no exact
values for the mass density of a-synuclein molecules inside a ﬁbril. Detailed
structural information about the ﬁbril architecture is necessary to reach a
more accurate estimate of the mass density.
A second conversion is that between the units in which length is mea-
sured. In the theory, the length of a ﬁbril is given as the degree of poly-
merization divided by the number of protoﬁlaments per ﬁbril, i.e., in terms of
a number of molecules, rather than in nanometers. The ‘‘length of one protein
molecule’’ along the ﬁbril long axis equals one inter-b-strand distance of
0.47 nm (26). A ﬁbril that contains four protoﬁlaments and has a length of
1 mm would thus contain ;8.5 3 103 monomers.
Finally, the theory requires that the conformation of the end monomers of
the ﬁbrils be speciﬁed. This can be done in three ways: we can force all ﬁbril
ends to be in a non-b-conformation, we can ﬁx them in a b-conformation, or
we can allow them to attain either of these conformations (21). The ﬁrst of
these boundary conditions causes the model to predict the formation of un-
realistically long ﬁbrils for reasonable values of the free-energy parameters.
The other two descriptions of ﬁbril end conformation yield realistic, and
equivalent, results. We chose to allow both conformations since the actual
conformation of ﬁbril ends is not known.
Estimation of concentration of a-synuclein in a
neural cell
To relate the critical concentration for a-synuclein ﬁbrillization found in our
theory and experiments to the in vivo situation, we estimate the concentration
of a-synuclein in a neural cell. It is estimated that a-synuclein (Ma¼ 14,460
g/mol) comprises a fraction of fa ﬃ 0.5%–1.0% % of brain cytosolic protein
(5). If we assume that proteins make up fp ¼ 20% of a cell’s weight and the
average mass density of a cell is rc¼ 1.03 g/ml (both estimates from Lodish
et al. (27)), we can approximate the concentration of a-synuclein in a neuron
as
ca ¼ na
Vc
¼ ma
MaVc
¼ fafprc
Ma
¼ 70 140mM
using na ¼ ma/Ma, ma ¼ fa fp mc, and mc ¼ rc Vc, where ca is the molar
concentration ofa-synuclein in the cell, na is the number ofmoles ofa-synuclein
in the cell, ma is the total mass of the a-synuclein, and Vc and mc are the cell
volume and mass, respectively, which cancel in the equation.
RESULTS
The extent of a-synuclein ﬁbrillization depends
on the initial protein concentration
Under the conditions employed in this investigation,a-synuclein
forms no ﬁbrillar aggregates when the initial concentration
is 5 or 10 mM (see representative images in Fig. 3, A and B).
The apparent lateral dimensions of these aggregates are ex-
aggerated by tip-sample convolution (;20 nm). Their height
is in the order of a few nanometers (see also Fig. 4).
The aggregation with an initial concentration of 20 mM
produced many small aggregates similar to those observed
for 5 and 10 mM and a small amount of short ﬁbrils, most of
them under 1 mm in length (Fig. 3 C). For higher concen-
trations (30 mM up to 250 mM), progressively more and
longer ﬁbrils were observed (Fig. 3, D–F).
The critical a-synuclein concentration for ﬁbril
formation is 15 mM
The ﬁbril length measurements for each initial concentra-
tion condition are summarized in the length distribu-
tion histograms shown in Fig. 4. The distribution of mature
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a-synuclein ﬁbril lengths depends on the initial protein
concentration: the distributions display a tail toward longer
ﬁbril lengths that becomes more pronounced at higher con-
centrations (Fig. 4). The shortest ﬁbrils (,100 nm in length)
at each aggregation condition are underrepresented in the
histograms because the tip-sample convolution and pixel
resolution require a minimum length for identiﬁcation as a
ﬁbril in the AFM images, in this case 40–80 nm.
To quantify the effect of increasing protein concentration,
the numerical average of the ﬁbril lengths was calculated
from each length distribution. Under our experimental con-
ditions, there is no signiﬁcant ﬁbrillization below a threshold
initial concentration of ;15 mM; above this concentration
progressively longer ﬁbrils form (Fig. 5). See the next section
for a discussion of the error on the critical concentration es-
timate. The vertical error bars at the 5 and 10 mM data points
FIGURE 3 AFM height images of wild-type
a-synuclein aggregates formed at initial protein
concentrations increasing from 5 to 250 mM.
All scale bars 1 mm.
FIGURE 4 Fibril length distributions for wild-type a-synuclein ﬁbrils formed in vitro from a range of initial protein concentrations (5, 10, 20, 30, 50, 100,
250 mM). For 5 and 10 mM samples, the aggregate height instead of length was measured as the indicator of aggregate size, since no signiﬁcant ﬁbrillization
occurred. The solid lines in the distributions for 20–250 mM are theoretical predictions using the same free-energy parameters as in Fig. 5. The reported n is the
number of ﬁbrils measured at each concentration. Bin sizes are 0.4 nm (for 5 and 10 mM concentrations) and 100 nm (20–250 mM).
Concentration Dependence of a-Synuclein Fibril Length 4875
Biophysical Journal 95(10) 4871–4878
in Fig. 5 are set to 20 nm because that is the ‘‘tip-sample
convolution resolution’’: the lateral size (‘‘length’’) of the
aggregates appears as 20 nm due to the ﬁnite AFM tip size,
but the real length is smaller. The resolution of the length
measurements is taken as the uncertainty on the means of the
other concentrations and is 40 nm for 20, 30, and 50 mM and
80 nm for the higher concentrations.
Comparison of the statistical-mechanical model
with mean ﬁbril lengths yields free energy
parameters of a-synuclein ﬁbrillization
We use the experimentally determined mean ﬁbril lengths to
establish the free energies of the interactions in a-synuclein
ﬁbrils as modeled by the statistical-mechanical model.
Although the original model contains four free-energy
parameters, only two of these parameters inﬂuence the pre-
dicted concentration dependence of the mean ﬁbril length.
These are the free energy of an interaction between b-folded
monomers P and the lateral-interaction free energy F (Fig. 1).
The other two parameters, which describe the interaction
between disordered protein molecules and the transition be-
tween a disordered and an ordered regime along the ﬁbril
axis, turn out to have a negligible effect. This observation
indicates that the mature ﬁbrils that dominate the system at
high enough protein concentrations contain very few disor-
dered protein molecules. A similar result was found by
Nyrkova and co-workers in their analysis of protein ﬁbril
formation by a synthetic peptide (28).
To quantitatively compare the experimental results to the
theory, we ﬁxed the values of all four free-energy param-
eters and calculated the unknown fugacity z from the pro-
tein concentration using Eq. 2. Subsequently, Eq. 8 was
used to calculate the mean ﬁbril length for the ﬁxed values
of the free-energy parameters and at the speciﬁed concen-
tration. By repeating this process for different values of u,
we obtain the dependence between the protein concentra-
tion and the mean ﬁbril length (Fig. 5). By systematically
varying the free-energy parameters P and F, we conclude
that the mean ﬁbril length at high concentrations depends
only on the b-bond free energy P and not on F, whereas the
predicted critical concentration depends on both free-energy
parameters. Observing the experimental results (Fig. 5), we
set the limits between which the critical concentration must
fall at 10 and 20 mM and use this as a criterion to determine
which values of the free energy parameters yield good
agreement between theory and experiment. We then specify
the error margin of the critical concentration as ccrit ¼ 15 6
5 mM. The constant slope of the curve (Fig. 5) at high
concentrations is virtually independent of the value of either
parameter.
Good agreement between theory and experiment is found
when the b-interaction free energy P lies between 6.3 and
6.0 times kBT and the lateral-association free energy F is
between 4.3 and 2.9 times kBT, with kB the Boltzmann’s
constant and T the absolute temperature. The solid line in Fig.
5 shows the predicted concentration dependence of the mean
ﬁbril length for P ¼ 6.2 kBT and F ¼ 3.8 kBT. These
values correspond to P¼15.9 kJ/mol and F¼9.8 kJ/mol
at the ﬁbrillization temperature of 37C.
Using the same values for the free-energy parameters, we
compared theoretically calculated length distributions to
those measured by AFM. The statistical-mechanical model
reproduced the experimental results semiquantitatively for
concentrations above 10 mM (Fig. 4). We plotted the number
density (proportional to the number of ﬁbrils per unit volume)
of ﬁbrils with a length that falls within each speciﬁed interval
(expressed as a number of monomers m), divided by the total
ﬁbril number density. The total ﬁbril number density was
calculated by summation of the ﬁbril number density over all
ﬁbril lengths. This is summarized in Eq. 9.
Only ﬁbrils consisting of four protoﬁlaments were taken
into account in the calculation, because ﬁbrils that contain
fewer than the maximum allowed number of protoﬁlaments
tend to stay very short (21):
rðp ¼ 4;mÞ
rðp ¼ 4Þ ¼
rðp ¼ 4;mÞ
+
N
N¼1
rðp ¼ 4;mÞ
¼ ðksfzÞ4m8f 2m 1 ðksfzÞ
4
f
 
: (9)
The theory predicts an exponential decay of the number of
ﬁbrils of a given degree of polymerization with their length
(solid lines in Fig. 4). The theory provides an excellent pre-
diction for the fractions of long ﬁbrils, but the agreement is
FIGURE 5 Concentration dependence of mean a-synuclein ﬁbril length.
The data points are the mean lengths from the ﬁbril length distributions (Fig.
4), the solid line is the concentration dependence predicted by the statistical-
mechanical model (lateral binding free energy F ¼  3.8 kBT, binding free
energy between b-folded monomers P ¼ 6.2 kBT).
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less obvious for short ﬁbrils. In particular, fewer short ﬁbrils
(with lengths below a few hundred nanometers) are found
experimentally than would be expected from the model
prediction. This may be due to the ﬁnite resolution of the
AFM imaging and length measurement procedure. Both the
theory and the AFM measurements indicate that virtually no
ﬁbrils are formed in aggregations with initial protein con-
centrations of 5 and 10 mM.
DISCUSSION
The critical concentration for a-synuclein ﬁbrillization of
15 6 5 mM is in the same order of magnitude as an
earlier reported critical concentration for a-synuclein of 28
mM, determined by quantitative amino acid analysis (16).
The critical concentration is well below the estimated in vivo
concentration of a-synuclein in neural cells (70–140 mM).
This indicates the possibility of amyloid ﬁbril formation at
normal physiological conditions, not necessarily involving
overexpression of a-synuclein. The ﬁbril lengths we ﬁnd are
also realistic: ﬁbrils up to several micrometers do not have to
fold upon themselves to ﬁt in a Lewy body with an approx-
imate diameter of 10 mm.
The use of a single critical concentration for a polymeri-
zation process requires two assumptions, as explained in
Frieden (29). One assumption is that the equilibrium of the
conformational changes must be rapid relative to the equi-
librium of the monomers with the ﬁbrils. This assumption
certainly holds: monomer folding conversions typically take
place on the order of microseconds to milliseconds, and the
aggregation process is in the order of hours, even weeks.
The other implicit assumption one makes when using a
single critical concentration is that all monomeric conformers
interact with the ﬁbril. In the polymerization process dis-
cussed here, where it is likely that multiple conformations
exist (30), the case may be that there are monomeric con-
formers that do not add to the ﬁbrils. However, it is mainly
the kinetics of growth, not the morphology of the resulting
ﬁbrils, that would be affected. Sandal et al. report the de-
tection of various a-synuclein conformers based on force
spectroscopy data but also indicate that it is at present im-
possible to prove spectroscopically what conformation the
conformers actually possess (30). This being the case, and
given that the conformer equilibrium is much more rapid than
the ﬁbril formation process, the assumption that all mono-
mers are available for ﬁbril formation seems justiﬁed.
We determined the free energies of two types of bonds
within an a-synuclein amyloid ﬁbril: the free-energy differ-
ence between bound and unbound states of the monomers,
reﬂected by the parameter P, which we determined to lie
between 16.2 and 15.4 kJ/mol, and the free energy of the
lateral bond between two protoﬁlaments in a ﬁbril, reﬂected
by the parameter F, which is between 11.0 and 7.4 kJ/
mol. These values imply that the bonds that make up the ﬁ-
brils are;2–4 times as strong as a hydrogen bond in a protein
(;4.2–8.4 kJ/mol), four times as strong as a typical Van der
Waals interaction (;4.2 kJ/mol), and;20 times weaker than
a single covalent C-C bond (;347 kJ/mol).
The bond between the monomers in a protoﬁlament is
;1.5 times as strong as the bond between protoﬁlaments.
Considering nanodeformation experiments using AFM tips,
one would expect ‘‘unzipping’’ of protoﬁlaments to occur
rather than breakage of ﬁbrils perpendicular to the long axis.
This prediction is consistent with results on Ab reported
by Kellermayer et al., who used an AFM tip as a nano-
manipulation tool (31). Our value for the lateral association
free energy F is very similar to their free energy of lateral
binding of ;9.6 kJ/mol determined using mechanical un-
zipping of b-sheets from Ab ﬁbrils (31).
The statistical-mechanical model we employ holds under
two conditions. The ﬁrst is that the protein solution is dilute
enough that the effects of interaggregate interactions (such as
those of the excluded-volume type) may be neglected. This
condition is likely satisﬁed, as the a-synuclein concentrations
used in this investigation are in the micromolar range, and the
concentration of ﬁbrils is much lower still. The second con-
dition is that the processes described by the model are re-
versible, where the observed species can be reasonably
assumed to be in thermodynamic equilibrium with the sur-
roundings. Fibrillization of a-synuclein, as of Alzheimer’s
Ab protein (32), can be considered to be reversible: ﬁbrils
were shown to dissociate under high hydrostatic pressure
(33).
The application of the statistical-mechanical theory to
actual morphological data allows us to look in a new way at
the interactions involved in a-synuclein ﬁbrillization and to
quantify the strength of the bonds involved. The model is
equally applicable to other amyloid-forming proteins, pro-
vided that the maximum number of protoﬁlaments per ﬁbril
and the intermolecular distance along the ﬁbril long axis are
known. Its predictions of the mean ﬁbril length, the critical
concentration, and the fractions of ﬁbrils with a given length
will be valuable in establishing quantitative insights into the
biophysics of ﬁbril formation in other proteins. Detailed
analysis of the kinetics and energetics of the aggregation
process are essential to map the energy landscape for ﬁbril-
lization and to ﬁll in the gaps in suitable theoretical models
consistent with the physics of these complex biopolymer
systems. The existence of a critical concentration for ag-
gregation is particularly interesting because critical mono-
mer/nucleus concentration ﬂuctuations may trigger the onset
of nucleation (34), a process analogous to protein crystalli-
zation (35). Since there is a growing consensus that early
aggregate species are likely responsible for disease etiology,
detailed morphological studies of the intermediate species
around the critical concentration for ﬁbrillization will yield
key insights into potentially cytotoxic intermediates on the
pathway to ﬁbrillization and to the development of inter-
vention strategies for inhibition of aggregation or for ﬁbril
dissolution.
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